Table of Contents
Road to recovery: Modest revenue growth is expected due to ongoing reforms
Pharmaceutical Product Manufacturing in Australia
The industry comprises companies that manufacture medicinal and pharmaceutical products for human use from both synthetic (chemical) and natural sources. Other products include chemical or diagnostic testing agents, blood serums and biotech products. Industry activities include manufacturing active pharmaceutical ingredients and synthesising chemical ingredients, late-stage packaging and fill-finish activities.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.
Sanitary Paper Product Manufacturing in Australia
Industrial Gas Manufacturing in Australia
Pesticide Manufacturing in Australia
Medical and Surgical Equipment Manufacturing in Australia
Packaging Services in Australia
Veterinary Pharmaceutical Manufacturing in Australia
Brand Name Pharmaceutical Manufacturing in the US
Generic Pharmaceutical Manufacturing in the US
Over-the-Counter Medicine Manufacturing in the US
Medical Instrument & Supply Manufacturing in the US
Glasses & Contact Lens Manufacturing in the US
Pharmaceutical Raw Material Manufacturing in China
Pharmaceutical Manufacturing in China
Medical Supplies Manufacturing in China
Get Industry Insights. Simply.
Talk to Amrita
+1 718 303 2019
PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025 Summary Systemic Lupus Erythematosus (SLE) is a systemic inflammatory autoimmune disease ...
PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025 Summary Ulcerative Colitis (UC) is a type of chronic IBD that causes inflammation and ulcers in the innermost lining of ...
PharmaFocus: Tauopathies - Global Market Analysis Summary Tauopathies are a class of more than 20 neurodegenerative diseases characterized by tau protein aggregation in the brain. There are currently no ...